DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Eicosanoid metabolism via cyclooxygenases	#N/A	#N/A	prostaglandin D2	6305	pubchem
Mammalian disorder of sexual development	R-HSA-9830369	0	prostaglandin D2	6305	pubchem
Transcriptional regulation of testis differentiation	0	0	prostaglandin D2	6305	pubchem
Prostaglandin and leukotriene metabolism in senescence	0	0	prostaglandin D2	6305	pubchem
Quercetin and Nf-kB	#N/A	#N/A	prostaglandin D2	6305	pubchem
Arachidonic acid oxylipin metabolism	R-HSA-2142753	0	prostaglandin D2	6305	pubchem
Metabolism	R-HSA-1430728	0	Alitretinoin	449171	pubchem
Biological oxidations	R-HSA-211859	0	Alitretinoin	449171	pubchem
Phase I - Functionalization of compounds	R-HSA-211945	0	Alitretinoin	449171	pubchem
Cytochrome P450 - arranged by substrate type	R-HSA-211897	0	Alitretinoin	449171	pubchem
Vitamins	R-HSA-211916	0	Alitretinoin	449171	pubchem
Signaling Pathways	R-HSA-9824443	0	Alitretinoin	449171	pubchem
Signaling by Nuclear Receptors	R-HSA-9006931	0	Alitretinoin	449171	pubchem
Signaling by Retinoic Acid	R-HSA-5362517	0	Alitretinoin	449171	pubchem
RA biosynthesis pathway	R-HSA-5365859	0	Alitretinoin	449171	pubchem
Disease	R-HSA-1643685	0	Alitretinoin	449171	pubchem
Diseases of metabolism	R-HSA-5668914	0	Alitretinoin	449171	pubchem
Metabolic disorders of biological oxidation enzymes	0	0	Alitretinoin	449171	pubchem
Defective CYP26C1 causes FFDD4	R-HSA-5579004	0	Alitretinoin	449171	pubchem
PPAR signaling pathway	R-HSA-168638	map03320	Alitretinoin	449171	pubchem